Penserra Capital Management »

Keros Therapeutics shares owned by Penserra Capital Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Penserra Capital Management from 13F filings

Historical chart of Penserra Capital Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Penserra Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Penserra Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $383k 19k 20.33
2021-09-30 $21k 535 39.25
2021-06-30 $22k 530 41.51
2021-03-31 $32k 520 61.54
2020-12-31 $37k 530 69.81